AL
Alkermes
ALKS·NASDAQDublin IEFounded 19872,200 employees
Mid CapbiotechPublicCNS
Platform: Lybalvi CNS
Market Cap
$5B
All Drugs
3
Clinical Trials
7
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (ALKS)
Loading ALKS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelicilimab | ALK-6499 | Phase 3 | 4 | PD-1 | UCHuntington's | ||
| ALK-5502 | ALK-5502 | Phase 1 | 1 | PLK4 | Huntington's | ||
| ALK-4522 | ALK-4522 | Phase 1 | 2 | WRN | HS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (7)